XML 114 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule of Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]    
Net earnings $ 6,283 $ 4,023
Stock-based compensation 490 372
decrease (Increase) in other assets (4,925) 196
(Decrease) in other liabilities 939 1,432
Net cash provided by operating activities 6,882 10,360
Proceeds from sale of preferred stock 15,000
Proceeds from sale of common stock 324 9,866
Net cash provided by financing activities 197,606 232,308
Net increase in cash and cash equivalents 4,827 12,866
Cash and cash equivalents at beginning of the year 71,836 58,970
Cash and cash equivalents at end of the year 76,663 71,836
Parent Company [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net earnings 6,283 4,023
Stock-based compensation 490 372
Equity in undistributed income of subsidiary (7,254) (4,792)
decrease (Increase) in other assets 1,943 (306)
(Decrease) in other liabilities (63) 431
Net cash provided by operating activities 1,399 (272)
Capital infusion to bank subsidiary (1,500) (24,500)
Proceeds from sale of preferred stock 15,000
Proceeds from sale of common stock 324 9,866
Net cash provided by financing activities 324 24,866
Net increase in cash and cash equivalents 223 94
Cash and cash equivalents at beginning of the year 602 508
Cash and cash equivalents at end of the year 825 602
Change in accumulated other comprehensive loss of subsidiary, net change in unrealized loss on debt securities available for sale, net of income taxes 511 (5,191)
Reduction in investment in subsidiary due to adoption of ASC 326 $ 181